Questions About Cancer? 1-800-4-CANCER
  • Print
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI Drug Dictionary


sargramostim plasmid DNA hepatocellular carcinoma vaccine adjuvant 
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (granulocyte-macrophage colony-stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered hepatocellular carcinoma vaccine. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:GM-CSF plasmid DNA hepatocellular carcinoma vaccine adjuvant
Abbreviation:phGM-CSF HCC